Isolite and Dental Treatment Under Conscious Sedation

Sponsor
The University of Texas Health Science Center at San Antonio (Other)
Overall Status
Completed
CT.gov ID
NCT01683851
Collaborator
(none)
20
2
10
10
1

Study Details

Study Description

Brief Summary

Hypothesis

The use of Isolite® system does not produce upper airway obstruction in the pediatric population during dental treatment with conscious sedation.

Purpose:

Report the changes in airway patency and pediatric patient's behavior when Isolite® system is used for dental treatment with conscious sedation.

Objectives:
  1. Determine changes in pulse rate

  2. Determine changes in SpO2

  3. Recognize breath sound's changes possibly associated with airway blockage

  4. Evaluate if the isolite® system is well tolerate by the pediatric population for dental treatment under conscious sedation

  5. Relate the use of Isolite® with the frequency of head reposition to open the airway.

Condition or Disease Intervention/Treatment Phase
  • Device: Isolite System

Detailed Description

Report the changes in airway patency and pediatric patient's behavior when Isolite® system is used for dental treatment with conscious sedation.

Study Design

Study Type:
Observational
Actual Enrollment :
20 participants
Time Perspective:
Prospective
Official Title:
Isolite and Dental Treatment Under Conscious Sedation: a Pilot Study to Assess the Upper Airway in a Pediatric Population
Study Start Date :
Aug 1, 2012
Actual Primary Completion Date :
Jun 1, 2013
Actual Study Completion Date :
Jun 1, 2013

Outcome Measures

Primary Outcome Measures

  1. Isolite and Dental Treatment Under Conscious Sedation [120 minutes (sedation appointment time)]

    In this study all patients were Mallampati 1 and Brodsky 2. The device comes in 4 sizes: pedo, small, medium and large. The most commonly used was pedo 65% (13) and small 35% (7). Eighty percent (16) of sedations had a satisfactory experience with Isolite ®, Twenty percent (4) had unsatisfactory outcome due to disruptive behavior. Of these 4 cases 2 patients were medicated with meperidine + hydroxyzine and the other 2 with midazolam. Fifty percent (8) of the patients successfully treated with Isolite ® experienced snoring and head reposition was performed to open airway. The level of sedation according to the AAPD guidelines was moderate in these events in which snoring occurred. The concentration of nitrous oxide-oxygen was adjusted so that more oxygen was given and the patient would be more alert. No significant changes in SpO2 (mean 99.8) or pulse were observed (mean 90.6).

Secondary Outcome Measures

  1. Isolite and Dental Treatment Under Conscious Sedation [120 minutes (sedation appointment)]

    Finally, it is important to recognize that this is a pilot study with limitations, including: A small number of participants No group control Therefore, this study's findings need to be tempered by implications contained within these limitations and further research seems indicated. Conclusions: The results of this pilot study suggest the following conclusions: Isolite ® may be safely used during pediatric dental treatment under conscious sedation. The successful use of Isolite ® is related to the patient's behavior. The weakness aspect of Isolite ® is the soft bite block that allows the youngest patients to chew on it. Therefore, this study's findings need to be tempered by implications contained within these limitations and further research seems indicated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 7 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASA I (no systemic disease), ASA II (mid systemic disease-well controlled)

  • 4-7 years of age

  • Patients English and Spanish speaking

Exclusion Criteria:
  • Upper airway infection

  • Craniofacial anomalies

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas Health Science Center-Dental School San Antonio Texas United States 78229
2 University of Texas Health Science Center-Ricardo Salinas Dental Clinic San Antonio Texas United States 78237

Sponsors and Collaborators

  • The University of Texas Health Science Center at San Antonio

Investigators

  • Principal Investigator: Claudia I Contreras, DDS, University of Texas

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Claudia Isabel Contreras, Professor, The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT01683851
Other Study ID Numbers:
  • HSC200120233H
First Posted:
Sep 12, 2012
Last Update Posted:
Dec 13, 2013
Last Verified:
Dec 1, 2013
Keywords provided by Claudia Isabel Contreras, Professor, The University of Texas Health Science Center at San Antonio
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 13, 2013